Harvey Masonson

1.1k total citations · 1 hit paper
6 papers, 654 citations indexed

About

Harvey Masonson is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Harvey Masonson has authored 6 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Ophthalmology, 4 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Molecular Biology. Recurrent topics in Harvey Masonson's work include Retinal Diseases and Treatments (5 papers), Retinal and Optic Conditions (3 papers) and Retinal Imaging and Analysis (3 papers). Harvey Masonson is often cited by papers focused on Retinal Diseases and Treatments (5 papers), Retinal and Optic Conditions (3 papers) and Retinal Imaging and Analysis (3 papers). Harvey Masonson collaborates with scholars based in United States, Spain and Italy. Harvey Masonson's co-authors include Keith Westby, Glenn J. Jaffe, Joel Pearlman, Jordi Monés, John Randolph, Sunil Patel, Karl G. Csaky, Brian C. Joondeph, Kourous A. Rezaei and Rajendra S. Apte and has published in prestigious journals such as Ophthalmology, American Journal of Ophthalmology and British Journal of Ophthalmology.

In The Last Decade

Harvey Masonson

6 papers receiving 626 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration

2020 307 citations Glenn J. Jaffe, Keith Westby et al. Ophthalmology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Harvey Masonson United States	6	497	324	248	53	36	6	654
Keith Westby United States	5	461 0.9×	303 0.9×	258 1.0×	63 1.2×	36 1.0×	6	632
Tsuyoshi Otsuji Japan	11	656 1.3×	440 1.4×	267 1.1×	26 0.5×	16 0.4×	20	772
Yumiko Saishin United States	10	440 0.9×	254 0.8×	336 1.4×	30 0.6×	30 0.8×	10	639
K. Eibl Germany	18	585 1.2×	420 1.3×	267 1.1×	21 0.4×	54 1.5×	44	785
Shiqi Yang China	10	368 0.7×	230 0.7×	348 1.4×	68 1.3×	26 0.7×	23	670
Peter Lundh von Leithner United Kingdom	8	359 0.7×	240 0.7×	251 1.0×	51 1.0×	18 0.5×	10	490
J. Fant United States	8	237 0.5×	207 0.6×	263 1.1×	30 0.6×	50 1.4×	10	511
Lucian Del Priore United States	8	369 0.7×	226 0.7×	165 0.7×	19 0.4×	13 0.4×	12	468
Iris Navarro United States	14	402 0.8×	155 0.5×	297 1.2×	33 0.6×	74 2.1×	21	591
Gulnar Hafiz United States	18	1.2k 2.4×	729 2.3×	326 1.3×	33 0.6×	26 0.7×	24	1.4k

Countries citing papers authored by Harvey Masonson

Since Specialization

Citations

This map shows the geographic impact of Harvey Masonson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harvey Masonson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harvey Masonson more than expected).

Fields of papers citing papers by Harvey Masonson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harvey Masonson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harvey Masonson. The network helps show where Harvey Masonson may publish in the future.

Co-authorship network of co-authors of Harvey Masonson

This figure shows the co-authorship network connecting the top 25 collaborators of Harvey Masonson. A scholar is included among the top collaborators of Harvey Masonson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harvey Masonson. Harvey Masonson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Jaffe, Glenn J., Keith Westby, Karl G. Csaky, et al.. (2020). C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration. Ophthalmology. 128(4). 576–586. 307 indexed citations breakdown →

2.

Jaffe, Glenn J., Thomas A. Ciulla, Antonio P. Ciardella, et al.. (2016). Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration. Ophthalmology. 124(2). 224–234. 114 indexed citations

3.

Singerman, Lawrence J., Harvey Masonson, M. Patel, et al.. (2008). Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial. British Journal of Ophthalmology. 92(12). 1606–1611. 107 indexed citations

4.

Apte, Rajendra S., et al.. (2007). Pegaptanib 1-Year Systemic Safety Results from a Safety–Pharmacokinetic Trial in Patients with Neovascular Age-Related Macular Degeneration. Ophthalmology. 114(9). 1702–1712.e2. 82 indexed citations

5.

Cook, David J., et al.. (1988). Effect of cold air on aqueous humor dynamics in humans.. PubMed. 29(1). 138–40. 31 indexed citations

6.

Yablonski, Michael E., et al.. (1987). Use of Therapeutic Ultrasound to Restore Failed Trabeculectomies. American Journal of Ophthalmology. 103(4). 492–496. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact